NUTI, Marianna
 Distribuzione geografica
Continente #
NA - Nord America 6.662
EU - Europa 3.050
AS - Asia 1.451
AF - Africa 88
SA - Sud America 63
OC - Oceania 6
Totale 11.320
Nazione #
US - Stati Uniti d'America 6.592
IT - Italia 1.458
SG - Singapore 563
SE - Svezia 447
IN - India 396
CN - Cina 327
UA - Ucraina 298
FI - Finlandia 237
DE - Germania 184
IE - Irlanda 85
GB - Regno Unito 75
RU - Federazione Russa 62
CA - Canada 60
AR - Argentina 55
ID - Indonesia 46
BG - Bulgaria 39
KR - Corea 36
EG - Egitto 33
FR - Francia 32
HK - Hong Kong 30
NL - Olanda 30
TG - Togo 30
CH - Svizzera 23
RO - Romania 19
IR - Iran 15
BE - Belgio 14
ZA - Sudafrica 14
MX - Messico 9
ES - Italia 8
PL - Polonia 8
JP - Giappone 7
DK - Danimarca 6
MA - Marocco 6
TW - Taiwan 6
AU - Australia 5
GR - Grecia 5
BR - Brasile 4
PT - Portogallo 4
TR - Turchia 4
AT - Austria 3
CI - Costa d'Avorio 3
CO - Colombia 3
KZ - Kazakistan 3
LK - Sri Lanka 3
MK - Macedonia 3
NO - Norvegia 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
CZ - Repubblica Ceca 2
LT - Lituania 2
MY - Malesia 2
RS - Serbia 2
SC - Seychelles 2
CL - Cile 1
CU - Cuba 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MV - Maldive 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VN - Vietnam 1
Totale 11.320
Città #
Fairfield 971
Rome 626
Chandler 549
Woodbridge 510
Ashburn 464
Seattle 383
Houston 369
Singapore 362
Cambridge 337
Wilmington 289
Ann Arbor 268
Princeton 183
Plano 142
San Paolo di Civitate 135
Santa Clara 132
New York 130
Beijing 128
Jacksonville 118
Helsinki 101
Lawrence 99
Millbury 91
Dublin 85
Boston 79
San Diego 79
Milan 71
Dearborn 67
Andover 57
Boardman 46
Jakarta 46
Federal 43
Norwalk 39
Sofia 39
Des Moines 35
Fremont 32
Bremen 30
Lomé 30
Damanhur 29
Falls Church 24
Moscow 24
Toronto 24
Hong Kong 23
Falkenstein 21
Florence 21
Hyderabad 20
Perugia 18
Shanghai 16
Los Angeles 15
York 15
Brussels 14
San Mateo 14
Phoenix 13
Guangzhou 12
Indore 12
London 12
Ottawa 12
Latina 11
Palermo 11
Redwood City 11
Leawood 10
Salt Lake City 10
Turin 10
Albano Laziale 9
Mannheim 9
Dallas 8
Montreal 8
Munich 8
Seongnam 8
Udine 8
Buffalo 7
Fuzhou 7
Hefei 7
Mexico City 7
Nanjing 7
Reggio Calabria 7
Stockholm 7
Wuhan 7
Bühl 6
Chicago 6
Frankfurt am Main 6
Grafing 6
Hangzhou 6
Johannesburg 6
Kunming 6
Lappeenranta 6
Livorno 6
Modena 6
Naples 6
Philadelphia 6
Seoul 6
Southend 6
Washington 6
Diano d'Alba 5
Jena 5
Muizenberg 5
Nanchang 5
Novosibirsk 5
Pomezia 5
San Isidro 5
Siano 5
Taipei 5
Totale 7.816
Nome #
“LISATO PIASTRINICO, USI DI ESSO E METODO PER LA SUA PREPARAZIONE” 222
Circulating CD137 + T cells correlate with improved response to anti-PD1 immunotherapy in cancer patients 156
TK inhibitor pazopanib primes DCs by downregulation of the β-catenin pathway 154
The macrophage Galactose-type C-type Lectin (MGL) modulates regulatory T cell functions 139
Bevacizumab-based chemotherapy triggers immunological effects in responding multi-treated recurrent ovarian cancer patients by favoring the recruitment of effector t cell subsets 133
Cancer immunotherapy in patients with brain metastases 131
The sexist behaviour of immune checkpoint inhibitors in cancer therapy? 123
Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: clinical and immunological data of a phase I/II clinical trial 121
Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment 117
Evidence for multipotent endodermal stem/progenitor cell populations in human gallbladder 114
Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma 113
Transplantation of stem/progenitor cells isolated from human fetal biliary tree into two patients with advanced liver cirrhosis 112
Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells 111
Anisakis pegreffii impacts differentiation and function of human dendritic cells 108
Tumor associated MUC1 carried by microvesicles is cross-processed by dendritic cells generating CD8+ T cell response 107
A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab 107
Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC? 104
Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: relief from immunosuppression is associated with clinical response 101
Anti–PD-1 and Anti–PD-L1 in head and neck cancer: a network meta-analysis 100
Tumor Associated Tn-MUC1 Glycoform is Internalized through the Macrophage Galactose-type C-type Lectin and delivered to the HLA Class I and II Compartments in Dendritic Cells. 98
MGL receptor and immunity: when the ligand can make the difference 98
CAR-T with License to Kill Solid Tumors in Search of a Winning Strategy 94
Tumor-derived microvesicles modulate antigen cross-processing via reactive oxygen species-mediated alkalinization of phagosomal compartment in dendritic cells 93
The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer. A meta-analysis 91
The agnostic role of site of metastasis in predicting outcomes in cancer patients treated with immunotherapy 91
Transplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis. 89
Past, present and future strategies of immunotherapy in gynecological malignancies 87
Immune effects of trastuzumab. 87
Immunological and clinical impact of cancer stem cells in vulvar cancer: role of CD133/CD24/ABCG2-Expressing Cells 87
The microbiota impact. bacteria shaping immunity, disease and response to therapy 86
Antigenic heterogeneity of human mammary carcinoma cells defined by monoclonal antibodies 85
Tumor derived Microvesicles enhance cross-processing ability of clinical grade Dendritic Cells 85
Adoptive immunotherapy with cytokine-induced killer cells generated with a new good manufacturing practice-grade protocol 85
Cancer testis antigen expression in primary and recurrent vulvar cancer: Association with prognostic factors 84
null 83
Microvesicle cargo of tumor-associated MUC1 to dendritic cells allows cross-presentation and specific carbohydrate processing. 82
Counting of leukocytes in samples from G-CSF mobilized donors, leukapheresis products, and cord blood: the performances of an analyzer with dedicated profiles. 82
Multicentre harmonisation of a six-colour flow cytometry panel for naïve/memory T cell immunomonitoring 81
Human antibodies against the polymorphic epithelial mucin in ovarian cancer patients recognise a novel sequence in the tandem repeat region 81
Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression 80
Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment 80
Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer 79
Anticorpi monoclonali contro la lipasi da Candida rugosa 79
Successful isolation, culturing and differentiation in vitro and in vivo of multipotent stem cells (mps) from human fetal biliary tree. 78
Multiple Tumor Associated Peptide Vaccination As Consolidation Treatment In Women Affected by Breast and Ovarian Cancer 76
Characterization of monoclonal antibody 436 recognizing the ARG-PRO-ALA-PRO sequence of the polymorphic epithelial mucin (PEM) protein core in breast carcinoma cells 76
A monoclonal antibody D 612 with selective reactivity for malignant and normal gastrointestinal epithelium 76
Complete remission of ovarian cancer induced intractable malignant ascites with intraperitoneal bevacizumab. Immunological observations and a literature review 75
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach 74
Death from Metastatic Donor-Derived Ovarian Cancer in a Male Kidney Transplant Recipient 74
The impact of locoregional treatment on response to Nivolumab in advanced platinum refractory head and neck cancer: the NEED TRIAL 74
The role of soluble LAG3 and soluble immune checkpoints profile in advanced head and neck cancer: a pilot study 74
Current knowledge and open issues regarding Bevacizumab in gynaecological neoplasms 74
Marker Expression and differentiation in human breast cancer 73
High frequency production of hybridomas secreting antibodies to cell antigens. 73
Exploratory pilot study of circulating biomarkers in metastatic renal cell carcinoma 73
Recombinant tumor-associated MUC1 glycoprotein impairs the differentiation and function of dendritic cells. 73
The 5-Ws of immunotherapy in head and neck cancer 72
A comparative analysis of serum and serum-free media for generation of clinical grade DCs 71
Human decay accelerating factor transgenic pigs for xenotransplantation obtained by sperm-mediated gene transfer 71
Funzione immunoregolatoria dell'antigene tumore associato MUC1 durante l'ematopoiesi 70
Quantitative determination of mammary tumor virus in individual samples of mouse milk 70
GALLBLADDER IS A HIGHLY AVAILABLE SOURCE OF STEM CELLS WITH MULTIPLE ENDODERMIC MATURE FATES POTENTIALITY 70
HUMAN DUODENAL SUBMUCOSAL GLANDS CONTAIN STEM CELLS WITH POTENTIAL FOR LIVER AND PANCREATIC FATES 69
Human duodenal submucosal glands contain a defined stem/progenitor subpopulation with liver-specific regenerative potential 68
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line 68
Immunological backbone of uveal melanoma: is there a rationale for immunotherapy? 68
A spectrum of monoclonal antibodies reactive with humam mammary tumor cells 67
Distinct pathways of antigen processing of MUC1 tumor-associated glycoprotein in dendritic cells (DCs) 67
The role of growth factor administration and T-cell recovery after peripheral blood progenitor cell transplantation in the treatment of solid tumors: results from a randomized comparison of G-CSF and GM-CSF. 67
Cellular Adaptive Immune System Plays a Crucial Role in Trastuzumab Clinical Efficacy 66
Circulating CD137+ T cell levels are correlated with response to pembrolizumab treatment in advanced head and neck cancer patients 65
Recombinant tumor associated MUC1 glycoprotein impairs the differentiation and function of dendritic cells. 65
null 64
Network analysis of gut microbiome and metabolome to discover microbiota-linked biomarkers in patients affected by non-small cell lung cancer 64
Immunology of Gynecologic Neoplasms: Analysis of the Prognostic Significance of the Immune Status 63
International Journal Oncology 63
Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1 63
MGL lectin receptor and immunosuppression networks in glioblastoma 62
Principles of cancer chemotherapy in children. 62
N-methylformamide effects on cell proliferation and antigenic pattern in HT-29 colon carcinoma cell line. 62
Quantitative comparison of milk released C3H and RIII mammary tumor viruses in infected Balb/c hosts 62
Transplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis 61
Regulated expression of MUC1 epithelial antigen in erythropoiesis 61
Circulating CD137+T cells as an immune biomarker for response to anti-PD1 immunotherapy in NSCLC patients 60
Mammary fetal gland:identification of new oncofetal antigens by monoclonal antibodies B72.3,MM 1-80 and 4.36. 60
Monoclonal antibodies in gynecological cancer: a critical point of view. 60
null 60
Cells with Characteristics of Cancer Stem/Progenitor Cells Express the CD133 Antigen in Human Endometrial Tumors 60
Use of monoclonal antibodies to human breast tumor associated antigens in fine needle aspirate cytology 59
HPV induced triple neoplasms: a case report 59
Presenza di anticorpi contro il virus di Hantaan in pazienti in emodialisi periodica 58
Effects of G-CSF and GM-CSF administration on T cell proliferation and phagocyte cell surface molecules during hematopoietic reconstitution after autologous peripheral blood progenitor cell transplantation 58
Immune response to the polymorphic epithelial mucin (PEM) 57
Monoclonal antibodies against Candida rugosa lipase 57
IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137 + T-cells 55
Interaction between treg cells and angiogenesis: A dark double track 54
Thinking twice before abandoning first-line chemotherapy in ovarian cancer: report of two cases and literature review. Passing from tri-weekly to weekly regimens 54
Immunohistochemical analysis of the distribution of a breast tumor associated antigen recognized by a monoclonal antibody 54
Macrophage galactose-like lectin mediated interactions: investigating immunosuppressive mechanisms in glioblastoma 53
Totale 8.182
Categoria #
all - tutte 38.957
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 1.031
selected - selezionate 0
volume - volumi 0
Totale 39.988


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.123 0 0 0 0 0 0 259 241 211 227 118 67
2020/20211.004 98 104 63 98 75 74 30 79 104 182 68 29
2021/20221.997 33 92 162 83 233 51 50 178 162 151 454 348
2022/20232.253 397 461 138 222 230 221 41 159 191 56 69 68
2023/20241.443 64 169 67 100 171 285 56 125 19 156 113 118
2024/20251.277 198 177 227 195 216 254 10 0 0 0 0 0
Totale 11.806